Unique sequences represent an new frontier in drug research. Such brief strings of amino residues present remarkable promise for interacting with intractable processes involved in various diseases. Early investigations indicate Nexaph peptides they can provide specific affinity and show desirable pharmacokinetic properties, creating paths to innova